{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:50:56Z","timestamp":1787496656180,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04070-1","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T21:25:41Z","timestamp":1759785941000},"page":"1198-1210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prognostic significance of liver-to-muscle FDG uptake ratio and \u0131nflammatory biomarkers in small cell lung cancer"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6091-730X","authenticated-orcid":false,"given":"Kadriye","family":"Ba\u015fkurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8175-8678","authenticated-orcid":false,"given":"Semra","family":"Demirta\u015f \u015eenlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0698-777X","authenticated-orcid":false,"given":"Galip Can","family":"Uyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-702X","authenticated-orcid":false,"given":"Enes","family":"Ye\u015filba\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2756-8646","authenticated-orcid":false,"given":"\u00d6m\u00fcr Berna","family":"\u00c7akmak \u00d6ks\u00fczo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3835-2741","authenticated-orcid":false,"given":"Osman","family":"S\u00fctc\u00fco\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"4070_CR1","doi-asserted-by":"publisher","first-page":"vi99","DOI":"10.1093\/annonc\/mdt178","volume":"24","author":"M Fr\u00fch","year":"2013","unstructured":"Fr\u00fch M, De Ruysscher D, Popat S, Crin\u00f2 L, Peters S, Felip E. Small-cell lung cancer (SCLC): esmo clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:vi99\u2013105.","journal-title":"Ann Oncol"},{"issue":"7563","key":"4070_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature14664","volume":"524","author":"J George","year":"2015","unstructured":"George J, Lim JS, Jang SJ, Cun Y, Ozreti\u0107 L, Kong G, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015;524(7563):47\u201353.","journal-title":"Nature"},{"issue":"23","key":"4070_CR3","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","volume":"379","author":"L Horn","year":"2018","unstructured":"Horn L, Mansfield AS, Szcz\u0119sna A, Havel L, Krzakowski M, Hochmair MJ, et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med. 2018;379(23):2220\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"4070_CR4","doi-asserted-by":"publisher","first-page":"20819","DOI":"10.1038\/s41598-020-77269-7","volume":"10","author":"RD Dolan","year":"2020","unstructured":"Dolan RD, Maclay JD, Abbass T, Colville D, Buali F, MacLeod N, et al. The relationship between 18F-FDG-PETCT-derived tumour metabolic activity, nutritional risk, body composition, systemic inflammation and survival in patients with lung cancer. Sci Rep. 2020;10(1):20819.","journal-title":"Sci Rep"},{"issue":"5","key":"4070_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.109589","volume":"51","author":"C White","year":"2025","unstructured":"White C, Jayaprakasam VS, Tenet M, Tang LH, Schattner MA, Janjigian YY, et al. PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinoma. Eur J Surg Oncol. 2025;51(5):109589.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"4070_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/01635581.2024.2392297","volume":"77","author":"L Tian","year":"2025","unstructured":"Tian L, Huang J-X, Wan R, Zhang J, Zhang X, Li N, et al. Association between sarcopenia, clinical outcomes, and survival in patients with extensive-stage small cell lung cancer treated with first-line immunochemotherapy: a prospective cohort study. Nutr Cancer. 2025;77(1):62\u20139.","journal-title":"Nutr Cancer"},{"issue":"1","key":"4070_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.chest.2019.04.115","volume":"156","author":"M Yang","year":"2019","unstructured":"Yang M, Shen Y, Tan L, Li W. Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis. Chest. 2019;156(1):101\u201311.","journal-title":"Chest"},{"issue":"5","key":"4070_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/JTO.0b013e3181d0a4f5","volume":"5","author":"M Paesmans","year":"2010","unstructured":"Paesmans M, Berghmans T, Dusart M, Garcia C, Hossein-Foucher C, Lafitte J-J, et al. Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project. J Thorac Oncol. 2010;5(5):612\u20139.","journal-title":"J Thorac Oncol"},{"issue":"39","key":"4070_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030798","volume":"101","author":"A Jin","year":"2022","unstructured":"Jin A, Lin X, Yin X, Cui Y, Ma L. Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: a meta-analysis. Medicine (Baltimore). 2022;101(39):e30798.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"4070_CR10","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s00259-013-2345-7","volume":"40","author":"RA Bundschuh","year":"2013","unstructured":"Bundschuh RA, Wendl CM, Weirich G, Eiber M, Souvatzoglou M, Treiber U, et al. Tumour volume delineation in prostate cancer assessed by [11C] choline PET\/CT: validation with surgical specimens. Eur J Nucl Med Mol Imaging. 2013;40(6):824\u201331.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"4070_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2214\/AJR.10.4923","volume":"195","author":"MC Adams","year":"2010","unstructured":"Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol. 2010;195(2):310\u201320.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"4070_CR12","volume":"4","author":"B Foster","year":"2018","unstructured":"Foster B, Boutin RD, Lenchik L, Gedeon D, Liu Y, Nittur V, et al. Skeletal muscle metrics on clinical 18F-FDG PET\/CT predict health outcomes in patients with sarcoma. J Nat Sci. 2018;4(5):e502.","journal-title":"J Nat Sci"},{"issue":"1","key":"4070_CR13","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1186\/s12885-024-13157-x","volume":"24","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhou J, Cai X, Ge S, Sang S, Yang Y, et al. Integrating 18F-FDG PET\/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer. BMC Cancer. 2024;24(1):1402.","journal-title":"BMC Cancer"},{"issue":"3","key":"4070_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10120-024-01485-7","volume":"27","author":"GA Vitiello","year":"2024","unstructured":"Vitiello GA, Jayaprakasam VS, Tang LH, Schattner MA, Janjigian YY, Ku GY, et al. Patient metabolic profile defined by liver and muscle 18F-FDG PET avidity is independently associated with overall survival in gastric cancer. Gastric Cancer. 2024;27(3):548\u201357.","journal-title":"Gastric Cancer"},{"key":"4070_CR15","unstructured":"Roshdy E, Ahmed T, Abdelhafez Y. Pretherapy Muscle 18F-FDG uptake: association with outcome in advanced head and neck cancer. Society of Nuclear Medicine; 2022."},{"issue":"10","key":"4070_CR16","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.21037\/qims-24-852","volume":"14","author":"X Xu","year":"2024","unstructured":"Xu X, Zhou J, Yao X, Sang S, Li J, Wang B, et al. The relationship between sarcopenia and metabolic parameters of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography (18F-FDG PET\/CT) and the prognostic value of sarcopenia in early-stage non-small cell lung cancer. Quant Imaging Med Surg. 2024;14(10):7098.","journal-title":"Quant Imaging Med Surg"},{"issue":"5","key":"4070_CR17","doi-asserted-by":"publisher","first-page":"8835","DOI":"10.18632\/oncotarget.13053","volume":"8","author":"F Zhang","year":"2016","unstructured":"Zhang F, Ying L, Jin J, Chen K, Zhang N, Wu J, et al. The c-reactive protein\/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer. Oncotarget. 2016;8(5):8835.","journal-title":"Oncotarget"},{"issue":"52","key":"4070_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000041087","volume":"103","author":"L Wang","year":"2024","unstructured":"Wang L, Long X, Zhu Y, Luo A, Yang M. Association of prognostic nutritional index with long-term survival in lung cancer receiving immune checkpoint inhibitors: a meta-analysis. Medicine (Baltimore). 2024;103(52):e41087.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4070_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11\u201348.","journal-title":"Clin Nutr"},{"issue":"7","key":"4070_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2024.101804","volume":"15","author":"J Hu","year":"2024","unstructured":"Hu J, Lan J, Xu G. Role of frailty in predicting prognosis of older patients with lung cancer: an updated systematic review and meta-analysis. J Geriatr Oncol. 2024;15(7):101804.","journal-title":"J Geriatr Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04070-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04070-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04070-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:05:26Z","timestamp":1774415126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04070-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":20,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["4070"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04070-1","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approved by the Clinical Research Ethics Committee of Etlik City Hospital (Approval No: AE\u015eH-BADEK-2024\u20131250). All procedures were conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No sponsor was involved in study design, data collection, analysis, or writing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sponsor\u2019s role"}}]}}